MedTrace Logo

Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia

NCT01649167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2012-07-25

No results posted yet for this study

Summary

Background: Obesity in pregnancy is increasing and is a risk factor for metabolic pathology such as preeclampsia. Leptin is an adipokine which has a direct relationship to obesity.

Aim: to measure leptin in lean, obese and diabetic pregnant women at three months intervals throughout their pregnancies.

Methods: Pregnant women were recruited in the 1st trimester of pregnancy, and three groups were formed: a) with pregestational Body Mass Index (BMI) less than 25 kg/m2, b) BMI higher than 25 kg/m2 and c) with Gestational Diabetes Mellitus (GDM). Serum levels of leptin were measured with radioimmunoassay (RIA) technique.

Conditions

  • High-Risk Pregnancy

Sponsors & Collaborators

  • Universidad Autonoma del Estado de Mexico

    collaborator OTHER

  • Materno-Perinatal Hospital of the State of Mexico

    lead OTHER

Principal Investigators

  • Verónica Jackeline García Solorio, MSc · Autonomous University of the State of Mexico

  • Hugo Mendieta Zerón, PhD · Autonomous University of the State of Mexico

Eligibility

Min Age
16 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Completion
2010-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01649167 on ClinicalTrials.gov